Suzie Vardanyan - Concepedia

Author

Suzie Vardanyan

Institute for Myeloma & Bone Cancer Research

Also Known As

C. Skevas, S Vardanyan, S. G. Vardanyan, S. Vardanyan, Suzie Vardanyan, V. Knospe

Publications

420

Citations

H-Index

Concepts

All Affiliations

Institute for Myeloma & Bone Cancer Research Oncotherapeutics (United States)University of California, Los Angeles

About

Suzie Vardanyan is an author at Institute for Myeloma & Bone Cancer Research specializing in medicine, oncology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	51
2	Immunology	2	2	34
3	Health Sciences	1	1	17
4	Cell Biology	1	1	19
5	Pathology	1	1	19

Suzie Vardanyan

Publications

372

Citations

H-Index

Page 1

	Year	Citations
Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients Michael Ghermezi, Mingjie Li, Suzie Vardanyan, Haematologica	2016	180
Soluble B-Cell Maturation Antigen Mediates Tumor-Induced Immune Deficiency in Multiple Myeloma Eric Sanchez, Abigail Gillespie, George Tang, Clinical Cancer Research	2016	105
Levels of uninvolved immunoglobulins predict clinical status and progression‐free survival for multiple myeloma patients Nika M Harutyunyan, Suzie Vardanyan, Michael Ghermezi, British Journal of Haematology	2016	25
Plasma B-Cell Maturation Antigen Levels are Elevated and Correlate with Disease Activity in Patients with Chronic Lymphocytic Leukemia Kyle A. Udd, Sean Bujarski, Eric Wirtschafter, Targeted Oncology Hematological MalignancyLymphoid NeoplasiaChronic Lymphocytic LeukemiaMixed-phenotype Acute LeukemiaImmunology	2019	19
Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib Ariana Berenson, Suzie Vardanyan, Michael David, Annals of Hematology Hematological MalignancyMedicineHematologyMyeloid NeoplasiaMultiple Myeloma Patients	2016	17
Risk of skin cancer in multiple myeloma patients: a retrospective cohort study Austin Robinson, James Wang, Suzie Vardanyan, European Journal Of Haematology Hematological MalignancyRetrospective Cohort StudyCancer ImmunosurveillanceCancer RiskCancer Epidemiology	2016	15
Increased M2 Macrophages in Multiple Myeloma Patients with Progressive Disease and Down-Regulated Polarization with the JAK2 Inhibitor Ruxolitinib Haiming Chen, Eric Sanchez, Mingjie Li, Blood	2014	11

Page 1